Expanding construct validity of established and new PROMIS Pediatric measures for children and adolescents receiving cancer treatment

Abstract

In a large, diverse sample of children and adolescents with cancer, there was strong evidence for the construct validity and responsiveness of the PROMIS Pediatric measures. This evidence supports PROMIS Pediatric measure use in pediatric oncology trials.